Data Insights (Chlorthalidone + losartan) by Laboratorios Silanes for Idiopathic (Essential) Hypertension: Likelihood of Approval
Data Insights SHJ-002 by Sunhawk Vision Biotech for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Data Insights Vesigel by UroGen Pharma for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Data Insights Hymecromone by Halo Biosciences for Primary Sclerosing Cholangitis: Likelihood of Approval
Partner Content CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System
Analyst Comment JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy GlobalData Healthcare
Analyst Comment “Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure Fiona Barry
Analyst Comment JP Morgan 2025: Almirall updates strategy with focus on medical dermatology Daniela Morales